Jam

FB Financial Corporation (FBK) declared a $0.19 per share quarterly cash dividend, payable November 25, 2025, to shareholders of record as of November 11, 2025. CEO Christopher T. Holmes cites the dividend as a reflection of the company’s strong performance and commitment to shareholder returns. The announcement arrives amid increased scrutiny of regional banks, with analysts watching key performance indicators to assess the long-term sustainability of FBK’s dividend policy in a challenging financial environment. FB Financial, with $16.2 billion in assets and 91 branches, operates in the Southeast.

CEO.CA featured Prince Silver Corp (PRNC) in its “Inside the Boardroom” series, highlighting the company’s aim to define an initial resource estimate by mid-2026. Prince Silver is targeting a potential 43+ million tonne Carbonate Replacement Deposit (CRD) silver deposit. The interview provides insights into Prince Silver’s strategy amid increasing investor interest in silver due to its precious metal and industrial applications. CEO.CA, a platform for investors in emerging markets, facilitates information sharing and connects investors with companies.

Autohome Inc. (ATHM; 2518.HK) will release its Q3 2025 financial results on November 6, 2025, before U.S. markets open. A conference call will be held at 7:00 AM ET. Analysts are focusing on the company’s performance in a changing Chinese automotive market, including the effectiveness of its AI content strategy and the success of Autohome Mall. A live and archived webcast will be available at https://ir.autohome.com.cn. Autohome is adapting to increased EV adoption and competition, striving to diversify its revenue beyond advertising.

Lake Victoria Gold reported exploration updates from Bulyanhulu Gold Mine (Barrick/Twiga owned) on six licenses acquired from LVG. Q2 2025 saw 12 RC holes drilled (1,380m) targeting the granite-greenstone contact, revealing mafic metavolcanics and alteration. LVG may receive up to US$45M in contingent payments based on future discoveries. Barrick will prioritize identified targets in Q3 2025. The drilling confirms geological continuity and validates long-standing interpretations of the belt’s potential.

Norsk Hydro’s Q3 2025 adjusted EBITDA decreased to NOK 5,996m due to lower alumina prices and a stronger NOK, while free cash flow remained strong at NOK 2.2bn, and net debt reduced to NOK 13.6bn. The company launched a cost reduction program targeting NOK 1bn annual savings from 2026 and secured a power agreement for Alouette through 2045. A Rotterdam court dismissed all 2021 claims against Hydro. They also divested Corvus Energy for USD 30m.

Linear Minerals Corp. shareholders approved a strategic restructuring at their annual meeting, including the spin-out of the Pontax West Lithium Property into a new subsidiary, Westlinear Minerals Corp. (Spinco). Shareholders will receive 1 Spinco share for every 10 Linear shares. Gurminder Sangha and four other directors were re-elected. The arrangement is subject to court and exchange approvals, and the Share Distribution Record Date will be announced later. This move aims to enhance focus and growth potential for both entities.

GSK’s *Blenrep* (belantamab mafodotin-blmf) has received FDA approval for relapsed or refractory multiple myeloma patients after at least two prior therapies. Backed by the DREAMM-7 trial, *Blenrep* combined with bortezomib and dexamethasone showed a 51% reduction in death risk and tripled progression-free survival compared to a daratumumab-based triplet. *Blenrep* is the only anti-BCMA agent accessible in community settings, with a streamlined REMS program. GSK is actively developing *Blenrep* for earlier lines of treatment, with ongoing trials and data expected in the coming years.

Provident Financial Holdings (NASDAQ: PROV) announced a quarterly cash dividend of $0.14 per share. Shareholders of record on November 13, 2025, will receive the dividend, payable on December 4, 2025. The company’s decision reflects confidence in its financial position and commitment to shareholder returns.

Archrock, Inc. (NYSE: AROC) declared a quarterly cash dividend of $0.145 per common share, payable May 15, 2024, to holders of record on May 7, 2024. This reflects Archrock’s financial stability and commitment to shareholder value amid evolving energy market dynamics. The company’s focus on efficient operations, advanced compression technologies, and sustainable solutions, including exploring alternative power sources, supports its long-term business model and resilience in a capital-intensive industry. Investors are monitoring Archrock’s strategies to balance returns with innovation and sustainability investments.

Ionis Pharmaceuticals, a leader in RNA-targeted therapeutics, debuted as a top employer in *Science* magazine’s survey, ranking second. The company excelled in innovation, values alignment, employee loyalty, and respect. This recognition coincides with Ionis’ progress in RNA therapeutics, developing antisense oligonucleotides for diseases like spinal muscular atrophy. CEO Brett Monia credits the company’s success to its people and culture, while Eric Swayze emphasizes their patient-centric approach. Ionis faces increasing competition in the RNA therapy market but aims to maintain its leadership through continued innovation and talent retention.